Abstract

The development of newer sensitive thyrotropin assays (sTSH) and of non-protein-bound free thyroxine assays (FT4) has led to conflicting

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call